Systemic treatments for women with breast cancer: outcome with relation to screening for the disease
Open Access
- 1 August 2003
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 14 (8) , 1212-1214
- https://doi.org/10.1093/annonc/mdg327
Abstract
Early detection and proper care of breast cancer are currently the best available approaches to the treatment of patients with the disease. In countries with a breast cancer screening programme, there has been a demonstrated reduction in breast cancer-related mortality. Such reduction has also been observed in Switzerland, a country in which no national programme of screening is available. Although there is no doubt that early diagnosis might have had a major role in reducing breast cancer mortality the magnitude of this effect is unknown. Research with tailored approaches on alternative imaging for early detection of breast cancer in high-risk women and on treatments offered according to proper criteria of responsiveness to therapies is warranted.Keywords
This publication has 12 references indexed in Scilit:
- Influence of delay to diagnosis on prognostic indicators of screen‐detected breast carcinomaCancer, 2002
- UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 yearsPublished by Elsevier ,2000
- Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancersAnnals of Oncology, 2000
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Ovarian ablation in early breast cancer: overview of the randomised trialsThe Lancet, 1996
- Aggressiveness of screen-detected breast cancersThe Lancet, 1995
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. The Australian and New Zealand Breast Cancer Trials Group, Clinical Oncological Society of Australia.Journal of Clinical Oncology, 1986
- Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1983